Versigent (NYSE:VGNT – Free Report) had its target price boosted by Wells Fargo & Company from $35.00 to $42.00 in a research report released on Wednesday,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock.
Several other equities research analysts have also commented on VGNT. UBS Group started coverage on shares of Versigent in a research report on Tuesday, April 14th. They set a “buy” rating and a $43.00 target price on the stock. Fox Advisors upgraded shares of Versigent to a “strong-buy” rating in a research report on Tuesday, April 7th. Deutsche Bank Aktiengesellschaft started coverage on shares of Versigent in a research report on Tuesday, April 28th. They set a “hold” rating and a $35.00 target price on the stock. Zacks Research upgraded shares of Versigent to a “hold” rating in a research report on Thursday, April 16th. Finally, TD Cowen started coverage on shares of Versigent in a research report on Tuesday, April 14th. They set a “buy” rating and a $47.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $44.00.
Get Our Latest Research Report on VGNT
Versigent Price Performance
Versigent (NYSE:VGNT – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $999.00 earnings per share for the quarter.
Recommended Stories
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
